CYP19A1 and cancer: The results of this study and the analysis highlight the binding affinities of these ligands against key proteins involved in cancer pathways: Epidermal growth factor receptor (EGFR, PDB ID: 1XKK), aromatase (PDB ID: 3S7S), and phosphoinositide 3-kinase alpha (PI3K alpha, PDB ID: 7PG6).